These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2903532)

  • 1. [Intrinsic sympathicomimetic activity of beta blockers].
    Beckers J
    Rev Med Liege; 1988 Oct; 43(19):613-22. PubMed ID: 2903532
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.
    Svendsen TL; Hartling OJ; Trap-Jensen J; McNair A; Bliddal J
    Clin Pharmacol Ther; 1981 Jun; 29(6):711-8. PubMed ID: 6112090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenoceptor blockade and intrinsic sympathomimetic activity--relevance in the treatment of ischaemic heart disease.
    Northcote RJ; Ballantyne D
    Scott Med J; 1985 Oct; 30(4):208-15. PubMed ID: 2869581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
    Noack E
    MMW Munch Med Wochenschr; 1982 Apr; 124(15):377-80. PubMed ID: 6123078
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of betablocking agents with and without intrinsic sympathicomimetic activity (ISA) on local wall-motion disorders in patients with coronary heart disease].
    Trieb G; Fassbender D; Schuster P; Gleichmann U
    Z Kardiol; 1982 Oct; 71(10):674-9. PubMed ID: 6130658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a review.
    Reale A; Motolese M
    Eur Heart J; 1981 Jun; 2(3):245-51. PubMed ID: 6115753
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapy of chronic heart failure with beta-receptor blockers?].
    Schwinger RH; Böhm M; Erdmann E
    Dtsch Med Wochenschr; 1990 May; 115(21):825-31. PubMed ID: 1971212
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atenolol in treatment of patients with airway obstruction].
    Chazan R
    Pol Merkur Lekarski; 1996 Dec; 1(6):428-30. PubMed ID: 9273241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers and the kidney: implications for renal function and renin release.
    Epstein M; Oster JR; Hollenberg NK
    Physiologist; 1985 Feb; 28(1):53-63. PubMed ID: 2858895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta blockers and heart failure].
    D'Amore F; Santoro AM; Schirripa R
    Clin Ter; 1997 Nov; 148(11):531-5. PubMed ID: 9494255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advantages of vasodilating beta-blockers in congestive heart failure].
    Logeart D; Solal AC
    Ann Cardiol Angeiol (Paris); 2010 Jun; 59(3):160-7. PubMed ID: 20620251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-adrenergic receptor blockers in the treatment of chronic heart failure].
    Mularek-Kubzdela T; Grajek S; Cieśliński A
    Pol Merkur Lekarski; 1996 Aug; 1(2):120-3. PubMed ID: 9156910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The place of beta-blockers in cardiovascular medicine.
    Cruickshank JM
    Cardiologia; 1995 Nov; 40(11):829-43. PubMed ID: 8706060
    [No Abstract]   [Full Text] [Related]  

  • 17. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous application of a beta-adrenergic sympathicomimetic and beta-adrenergic antagonist during inhibition of labor (author's transl)].
    Müller-Tyl E; Reinold E; Hernuss P
    Z Geburtshilfe Perinatol; 1974 Apr; 178(2):128-34. PubMed ID: 4154069
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blocking agents in heart failure: modern concepts and overview.
    Strauer BE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S129-32. PubMed ID: 11527116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology of nitrites and adrenergic beta blockaders in coronary circulation].
    Méndez R
    Arch Inst Cardiol Mex; 1980; 50(3):283-88. PubMed ID: 6107070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.